Artiva BiotherapeuticsARTV

13F holders, Q1 2025 (March 31)
53holders −4
3new positions
7sold out
1famous investor
$3.00avg. 13F price*

At the end of Q1 2025, 53 institutions reported holding Artiva Biotherapeutics Inc. (ARTV) in their 13F filings, down 4 from Q4 2024. 3 opened new positions and 7 sold out. The largest holders were Ra Capital Management, L.P. ($29.6M), 5AM Venture Management, LLC ($7.1M) and Venrock Adviser, LLC ($4.8M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Artiva Biotherapeutics Inc.
CUSIP
04317A107
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q3 2024: 49Q3 2024Q4 2024: 57Q4 2024Q1 2025: 53Q1 2025Q2 2025: 48Q2 2025Q3 2025: 40Q3 2025Q4 2025: 34Q4 2025Q1 2026: 40Q1 2026Q2 2026: 72Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions3$196K
Exits7$3.4M

All 13F filers, Q4 2024 → Q1 2025: 476,325 shares bought and 747,237 shares sold, net −270,912 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 53 holders

Ra Capital Management, L.P. 0.49% No change 9,853,302 $29.6M
5AM Venture Management, LLC 2.67% No change 2,353,304 $7.1M
Venrock Adviser, LLC 0.41% No change 1,609,569 $4.8M
BlackRock, Inc. 0.00% Add +19.0% 1,245,511 $3.7M
venBio Partners LLC 2.91% Reduce -21.1% 1,198,975 $3.6M
Capital World Investors 0.00% Reduce -5.3% 866,622 $2.6M
Vanguard Group Inc. 0.00% Reduce -1.0% 858,214 $2.6M
Franklin Resources Inc. 0.00% Add +0.0% 520,327 $1.6M
Geode Capital Management, LLC 0.00% Add +30.0% 410,457 $1.2M
Samsara Biocapital, LLC 0.16% No change 291,666 $875K
Woodline Partners LP 0.01% No change 283,124 $849K
Wellington Management Group LLP 0.00% No change 194,108 $582K
State Street Corp. 0.00% Add +4.3% 171,783 $515K
Logos Global Management LP 0.08% No change 145,089 $435K
Citadel Advisors 0.00% Add +40.0% 145,089 $435K
Northern Trust Corp. 0.00% Add +21.0% 141,676 $425K
Alyeska Investment Group, L.P. 0.00% No change 100,000 $300K
Charles Schwab Investment Management Inc. 0.00% Add +26.1% 54,881 $165K
Nuveen, LLC 0.00% — 47,892 $144K
Acuta Capital Partners, LLC 0.16% Add +3.3% 45,456 $136K
UBS Group AG 0.00% Add +21.8% 43,077 $129K
Goldman Sachs Group Inc. 0.00% Add +10.2% 41,952 $126K
Bank of New York Mellon Corp 0.00% No change 33,305 $100K
Sei Investments Co. 0.00% New 29,281 $88K
Morgan Stanley 0.00% Reduce -25.4% 27,820 $83K
Susquehanna International Group, LLP 0.00% New 24,357 $73K
Barclays PLC 0.00% Reduce -5.8% 22,753 $68K
Deutsche Bank AG 0.00% No change 21,423 $64K
JPMorgan Chase & Co. 0.00% Reduce -52.5% 17,883 $54K
Rhumbline Advisers 0.00% Add +12.5% 14,493 $43K
Citigroup Inc. 0.00% Reduce -8.1% 14,338 $43K
BNP Paribas Financial Markets 0.00% Add +33.9% 13,230 $40K
Wells Fargo & Company 0.00% Add +46.9% 12,659 $38K
Intech Investment Management LLC 0.00% New 11,547 $35K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% Add +42.8% 11,477 $34K
Corebridge Financial, Inc. 0.00% Add +33.6% 9,738 $29K
Bank of America Corp. 0.00% Reduce -23.3% 8,296 $25K
China Universal Asset Management Co., Ltd. 0.00% Reduce -5.4% 4,872 $15K
FMR LLC 0.00% Add +295.0% 3,555 $11K
Police & Firemen's Retirement System of New Jersey 0.00% No change 3,477 $10K
New York State Common Retirement Fund 0.00% No change 2,937 $9K
Tower Research Capital LLC (TRC) 0.00% Add +115.7% 2,614 $8K
Legal & General Group Plc 0.00% Add +44.9% 2,018 $6K
Ameritas Investment Partners, Inc. 0.00% No change 1,424 $4K
California State Teachers Retirement System 0.00% No change 1,041 $3K
Mirae Asset Global Investments Co., Ltd. 0.00% Add +0.5% 813 $3K
GF Fund Management Co. LTD. 0.00% Add +18.2% 603 $2K
Mark Sheptoff Financial Planning, LLC 0.00% Reduce -55.6% 400 $1K
Amalgamated Bank 0.00% No change 480 $1K
Royal Bank of Canada 0.00% Reduce -56.8% 478 $1K
Cwm, LLC 0.00% Add +40.1% 185 $1K
Nisa Investment Advisors, LLC 0.00% Add +281.4% 164 $492
Sterling Capital Management LLC 0.00% Reduce -26.9% 158 $474

"% of holder's portfolio" is ARTV's weight in each manager's 13F, not the share of Artiva Biotherapeutics Inc. the manager owns.